Secure Drug Supply Chain Act of 2026

This bill would require the Food and Drug Administration (FDA) to take steps to stop fake, unauthorized, or improperly labeled drugs from being brought into the United States from China and other foreign countries, and to put stronger protections in place for drugs that are imported. No official summary is available for this bill.

Your Vote